TLR9-and FcεRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression

被引:128
作者
Schroeder, JT
Bieneman, AP
Xiao, HQ
Chichester, KL
Vasagar, K
Saini, S
Liu, MC
机构
[1] Johns Hopkins Univ, Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Clin Immunol, Baltimore, MD 21224 USA
[2] Johns Hopkins Univ, Johns Hopkins Asthma & Allergy Ctr, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21224 USA
关键词
D O I
10.4049/jimmunol.175.9.5724
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Plasmacytoid dendritic cells (pDC) express not only TLR9 molecules through which ligation with CpG DNA favors Th1 responses but also possess IgE receptors (Fe epsilon RI) implicated in allergen presentation and induction of Th2 responses. This dichotomy prompted an investigation to determine whether TLR9- and IgE receptor-mediated responses oppose one another in pDC by affecting receptor expression and associated functional responses. Results showed that IgE cross-linking reduced TLR9 in pDC and inhibited the, capacity of these cells to secrete IFN-alpha when stimulated with the CpG oligodeoxynucleotide (ODN)-2216. In contrast, an similar to 15-fold reduction in Fc epsilon Ri alpha mRNA and a loss in surface protein were seen in pDC first exposed to TLR9 ligation with ODN-2216. Results indicated that type I IFNs partly mediated this effect, as rIFN-a also caused a significant similar to 4-fold reduction in Fc epsilon RI alpha mRNA. Finally, this reduction in FC epsilon RI alpha mediated by ODN-2216 correlated with a selective suppression of allergen-induced CD4(+) T cell proliferation, but not of responses resulting from tetanus toxoid. Overall, these results imply mechanisms by which specific innate and IgE-dependent immune responses counterregulate one another at the dendritic cell level and may have significant impact on whether an ensuing response is either of Th1 or Th2 in nature.
引用
收藏
页码:5724 / 5731
页数:8
相关论文
共 32 条
[1]  
ADKINSON NF, 1980, MANUAL CLIN IMMUNOLO, P800
[2]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[3]   New approaches in immunotherapy: allergen vaccination with immunostimulatory DNA [J].
Creticos, PS ;
Chen, YH ;
Schroeder, JI .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (04) :569-+
[4]   Plasmacytoid dendritic cells activate allergen-specific TH2 memory cells:: Modulation by CpG oligodeoxynucleotides [J].
Farkas, L ;
Kvale, EO ;
Johansen, FE ;
Jahnsen, FL ;
Lund-Johansen, F .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 114 (02) :436-443
[5]   Human dendritic cell 1 and dendritic cell 2 subsets express FcεF-RI:: Correlation with serum IgE and allergic asthma [J].
Foster, B ;
Metcalfe, DD ;
Prussin, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (06) :1132-1138
[6]  
GILBERT HS, 1975, BLOOD, V46, P279
[7]   CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells [J].
Hartmann, G ;
Weiner, GJ ;
Krieg, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) :9305-9310
[8]   Compartmental imbalance and aberrant immune function of blood CD123+ (plasmacytoid) and CD11c+ (myeloid) dendritic cells in atopic dermatitis [J].
Hashizume, H ;
Horibe, T ;
Yagi, H ;
Seo, N ;
Takigawa, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (04) :2396-2403
[9]   DNA-based immunotherapeutics for the treatment of allergic disease [J].
Horner, AA ;
Van Uden, JH ;
Zubeldia, JM ;
Broide, D ;
Raz, E .
IMMUNOLOGICAL REVIEWS, 2001, 179 :102-118
[10]   BIOLOGIC FUNCTION OF FC FRAGMENTS OF E-MYELOMA PROTEIN [J].
ISHIZAKA, K ;
ISHIZAKA, T ;
LEE, EH .
IMMUNOCHEMISTRY, 1970, 7 (08) :687-+